1. ICH (International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use) 1997 ICH S6: Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals
2. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412;Suntharalingam;N. Engl. J. Med.,2006
3. Does the TGN1412 trial disaster have lessons for clinical trials in India?;George;Natl. Med. J. India,2006
4. Lessons from TGN1412;Hanke;Lancet,2006
5. Establishing risk of human experimentation with drugs: lessons from TGN1412;Kenter;Lancet,2006